Clinical and epigenetic determinants of edentulism in type 2 diabetic subjects referring to a tertiary center
Edentulism, extreme consequence of severe periodontitis, carries a high cardiovascular and all-cause death risk. The prevailing phenotype of edentulous patients with type 2 diabetes (T2D) has never been defined, neither it is known whether an epigenetic signature of such condition exists. We collect...
Saved in:
Published in | Journal of diabetes and its complications Vol. 35; no. 5; p. 107910 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.05.2021
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Edentulism, extreme consequence of severe periodontitis, carries a high cardiovascular and all-cause death risk. The prevailing phenotype of edentulous patients with type 2 diabetes (T2D) has never been defined, neither it is known whether an epigenetic signature of such condition exists.
We collected clinical and biochemical data and administered a questionnaire on oral health in 248 consecutive T2D individuals. Vital status was checked after 17 ± 7 months. miRNAs involved in periodontal inflammation were measured.
Forty-seven patients (19%) were edentulous (ED), a higher prevalence than in the Italian general population (10.9% from ISTAT data). ED were older, with low level of instruction and higher fasting glucose vs not edentulous (noED). Participants displayed a scarce awareness of the association periodontitis-T2D. ED showed a specific epigenetic signature (lower miR214-5p and higher miR126-5p urinary levels). At the follow-up, metabolic profile similarly improved in ED and noED; death occurrence was similar.
In this cohort of T2D, age is the only variable associated with edentulism; such condition displays an epigenetic signature, independent of the clinical phenotype; awareness of the clinical relevance and implications of periodontitis and edentulism are scarce. However, edentulism does not mark an increased rate of micro-macrovascular complications or mortality.
•Edentulism is characterized by a high prevalence of CV morbidity and death.•In our cohort of T2D subjects, prevalence of edentulism is two-fold higher than in the general population.•Edentulism shows a peculiar epigenetic signature independent of the clinical phenotype.•Edentulism does not mark an increased rate of micro-macrovascular complications or mortality over a 2-year follow up. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1056-8727 1873-460X 1873-460X |
DOI: | 10.1016/j.jdiacomp.2021.107910 |